Precision Medicine within AstraZeneca focuses on matching medicines to those patients who will benefit from them most and delivers companion or complementary diagnostic assays that align with the drug development process and enable personalised healthcare approaches within our clinical portfolio.  

Precision Medicine Diagnostic Development Unit (DDU) China is based in Shanghai, China. Our mission is to coordinate the setup and operation of diagnostic assays (focusing on molecular and or tissue based Diagnostics in Oncology area) in Chinese labs for supporting Astrazeneca new drug development, as well as new drug registration and commercial business in China.  

This role will provide the opportunity to be part of the exciting development of precision medicine in a leading pharmaceutical company. Your work is going to make a real difference to patients, transforming patients’ lives through personalized treatments.

Date Posted

02-7月-2021

Closing Date

12-7月-2021

AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.